To Determine the Efficacy and Safety of DW1029M on Microalbuminuria in Patients With Diabetic Nephropathy
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 158 participants.
Also called NCT01935167
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 158 participants
- Sponsor
- Dong Wha Pharmaceutical Co. Ltd.
- Registry
-
NCT01935167
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT01935167. Randomized; double masking; primary purpose treatment. Start 2013-10 (registry gives no type); primary completion 2014-08 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- To Determine the Efficacy and Safety of DW1029M on Microalbuminuria in Patients With Diabetic Nephropathy
- Condition
- Diabetic Nephropathy
- Intervention (Drug)
- DW1029M 600mg
- Intervention (Drug)
- DW1029M 1200mg
- Intervention (Drug)
- Placebo
- Lead sponsor
- Dong Wha Pharmaceutical Co. Ltd.
Record details
- Record id
cardio:ct-nct01935167- Content hash
30b28a67cedca1fd6f7fd3c40ab7ecb5ba64e0e0a2e9054b80690d8c4da5e353